Brief: BB Biotech H1 Net Profit Down At CHF 422 Mln
July 24 (Reuters) - BB BIOTECH AG BION.S :
* NET PROFIT FOR FIRST HALF OF 2020 AMOUNTED TO CHF 422 MN,
RELATIVE TO CORRESPONDING PRIOR-YEAR FIGURE OF CHF 544 MN
* OUTLOOK: FURTHER PIPELINE PROGRESS AS WELL AS ONGOING IPOS
AND
CAPITAL INCREASES EXPECTED
Source text for Eikon: ID:nEQ1LQ1cxa
Further company coverage: BION.S
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Bb Biotech AG
See all newsBrief: BB Biotech Reports Net Profit Of CHF 451 Mln In Q2 2026
Switzerland's BB Biotech Q1 net loss narrows amid portfolio rotation
Brief: BB Biotech Reports Q1 Net Loss Of CHF 21 Million
Brief: BB BIOTECH Q1 Net Income CHF -21 Million
Brief: BB Biotech Says All Proposals Of Board Of Directors Approved At AGM